PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+41.54%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$6.16B
AUM Growth
+$6.16B
(+61%)
Cap. Flow
+$315M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
45.74%
Holding
148
New
33
Increased
26
Reduced
17
Closed
23
Top Buys
| 1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$58.1M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$45.8M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$39.3M |
| 4 |
Lyra Therapeutics
LYRA
|
$36.5M |
| 5 |
MacroGenics
MGNX
|
$36M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$112M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$62.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$40.5M |
| 4 |
Theravance Biopharma
TBPH
|
$23.1M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$22.9M |
Sector Composition
| 1 | Healthcare | 82.47% |
| 2 | Materials | 0.1% |
| 3 | Technology | 0.1% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALBO
26
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $51.9M | 0.84% |
1,960,139
| – | – |
|
|
NEPT
27
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $51.6M | 0.84% |
18,436,906
+5,000,000
| +37% | +$14M |
|
28
ADMA Biologics
ADMA
$4.05B
| $48.6M | 0.79% |
16,584,802
| – | – |
|
29
Agios Pharmaceuticals
AGIO
$2.32B
| $48.1M | 0.78% |
900,000
| – | – |
|
30
Rocket Pharmaceuticals
RCKT
$359M
| $45.8M | 0.74% |
2,189,010
| – | – |
|
|
31
Zentalis Pharmaceuticals
ZNTL
$122M
| $45.8M | 0.74% |
+1,050,003
| New | +$45.8M |
|
|
AGRX
32
DELISTED
Agile Therapeutics, Inc
AGRX
| $44.3M | 0.72% |
15,919,925
+600
| +0% | +$1.67K |
|
33
Black Diamond Therapeutics
BDTX
$165M
| $44M | 0.71% |
1,104,656
| – | – |
|
34
VYNE Therapeutics
VYNE
$8.03M
| $39.6M | 0.64% |
22,876,410
+16,239,231
| +245% | +$28.1M |
|
35
Verrica Pharmaceuticals
VRCA
$48.8M
| $37.5M | 0.61% |
3,410,412
| – | – |
|
|
36
Lyra Therapeutics
LYRA
$11.8M
| $36.5M | 0.59% |
+3,222,561
| New | +$36.5M |
|
37
Collegium Pharmaceutical
COLL
$1.23B
| $36M | 0.58% |
2,058,068
+506,346
| +33% | +$8.86M |
|
|
38
MacroGenics
MGNX
$118M
| $36M | 0.58% |
+1,288,014
| New | +$36M |
|
|
FUSN
39
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $36M | 0.58% |
+2,235,983
| New | +$36M |
|
|
MTEM
40
DELISTED
Molecular Templates, Inc.
MTEM
| $34.1M | 0.55% |
2,474,133
| – | – |
|
|
NARI
41
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $33.7M | 0.55% |
+696,000
| New | +$33.7M |
|
|
DBVT
42
DBV Technologies
DBVT
$257M
| $32.1M | 0.52% |
7,317,809
| – | – |
|
43
Avidity Biosciences
RNA
$6.03B
| $31.6M | 0.51% |
+1,235,818
| New | +$31.6M |
|
|
EIDX
44
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $30.1M | 0.49% |
686,922
| – | – |
|
45
Geron
GERN
$893M
| $29.3M | 0.48% |
+13,461,538
| New | +$29.3M |
|
46
Novavax
NVAX
$1.22B
| $29.2M | 0.47% |
+350,000
| New | +$29.2M |
|
47
Travere Therapeutics
TVTX
$1.7B
| $28.9M | 0.47% |
3,240,112
+349,504
| +12% | +$3.11M |
|
48
Vaxcyte
PCVX
$4.1B
| $26.9M | 0.44% |
+850,000
| New | +$26.9M |
|
49
Immunovant
IMVT
$2.89B
| $26.8M | 0.43% |
+1,100,000
| New | +$26.8M |
|
50
AtriCure
ATRC
$1.72B
| $23.8M | 0.39% |
528,776
+226,549
| +75% | +$10.2M |
|